![Placeholder Image Placeholder Image](https://www.novartis.com/us-en/sites/novartis_us/files/placeholder.jpeg)
Tags Archive Navigation
icon
-
StoryRemembering men’s health this National Veterans and Military Families Month
-
Media ReleaseNovartis confirms unconstrained supply for Pluvicto® and continues to significantly expand the number of treatment centers
-
Media ReleaseNovartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer